Know2eat

Lactoferrin

Animal-Derived

What lactoferrin may help with

Ranked by how strong the human evidence is — best supported first.

Best supportedIron statusLimited evidence· 3 sources

Then, in order

About Lactoferrin

An iron-binding glycoprotein found in milk, tears and other secretions, produced commercially from bovine whey. Supplements are the bovine protein, which is structurally similar but not identical to the human form.

Lactoferrin is one of the more biologically interesting animal-derived supplements: it binds iron with very high affinity, which underlies both its antimicrobial behaviour in laboratory work and its use as an iron supplement, and it interacts with intestinal receptors involved in iron uptake. The clinical picture is a lesson in trial size. Small Italian and Egyptian trials in pregnancy reported that lactoferrin raised haemoglobin comparably to ferrous sulfate with fewer gastrointestinal side effects, which is a genuinely useful finding if it holds. Against that, the largest trial in the field — ELFIN, in more than two thousand preterm infants in the UK — tested lactoferrin for late-onset infection and found no benefit, after smaller studies and meta-analyses had suggested there would be one. That pattern is worth remembering across this entire catalogue.

Sold as
Capsule, Powder, Apolactoferrin (iron-depleted), Added to infant formula in some markets
Standardised to
Milligrams of lactoferrin and iron saturation; apolactoferrin is the iron-free form used in most trials — a product without this marker may not resemble what was studied.
Also known as
Bovine lactoferrin, Apolactoferrin, Milk iron-binding protein

Regulation: Sold as a dietary supplement in the US with no pre-market efficacy review, and permitted as a food ingredient in several jurisdictions. It is not an approved medicine for iron deficiency anywhere, despite the pregnancy trial literature.

What the research used

The amounts, forms and durations published trials of Lactoferrin actually administered.

These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.

  • Studied for Iron deficiency in pregnancy

    100–200 mg

    Limited

    Apolactoferrin, once or twice daily · 4–8 weeks

    The dose in small Italian and Egyptian trials comparing it with ferrous sulfate. The trials were small and geographically clustered, and this is not an approved use anywhere.

  • Studied for Preterm infant infection trial

    150 mg

    Strong

    Daily, enterally, in preterm infants · Until 34 weeks corrected age

    The ELFIN trial protocol in more than two thousand infants. It found no reduction in late-onset infection, contradicting earlier smaller studies. Included here because the negative result is the most informative thing in the lactoferrin literature.

  • Studied for General adult supplement use

    200–600 mg

    Not enough

    Capsule, daily

    What retail products contain. There is no established adult dose for immune or gut outcomes.

This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.

When it was taken

Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.

None of the timings below were directly compared in a trial. They reflect how the research happened to dose, or what the pharmacology implies — which is not the same as a timing being better.

  • On an empty stomach

    Not enough

    Often taken away from food on the reasoning that gastric protein digestion degrades it and that dietary iron would saturate it. Enteric-coated forms exist for the same reason. This is pharmacological reasoning, not a tested comparison.

    Timing was not directly compared. This reflects convention or how the compound behaves in the body, not a trial showing this window works better.

The evidence in depth

Best supported: Limited

What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.

Iron status

Women's Health
Limited evidence

Small randomised trials in pregnant women with iron deficiency report increases in haemoglobin and ferritin comparable to ferrous sulfate, with fewer gastrointestinal complaints. The trials are small and concentrated in a few centres, and larger independent replication is what this finding needs.

What may be going on: Lactoferrin binds iron with high affinity and interacts with intestinal lactoferrin receptors, offering a route of iron uptake distinct from the ferrous salt pathway.

Limited evidence. Early human work, or mostly lab and animal research.

View the 3 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Gut microbiome

Gut & Digestive Health
Not enough evidence

Effects on gut bacteria and gut barrier markers have been reported in small studies and in animals. Human outcome evidence is not sufficient to support a gut claim.

Not enough evidence. Not enough human research to say anything useful yet.

View the 2 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Immune function

Immune Health
Not enough evidence

The largest trial in the field, in preterm infants, found no reduction in late-onset infection despite promising smaller studies beforehand. Adult trials for respiratory infection are small and inconsistent.

Not enough evidence. Not enough human research to say anything useful yet.

View the 4 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Things to know

Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.

  • Allergy

    Dairy allergen

    Bovine lactoferrin is a milk protein. Anyone with cow's milk protein allergy should avoid it, and products are frequently marketed without the dairy origin being obvious on the front of the label. It contains negligible lactose, so lactose intolerance is a separate and much smaller issue.

  • Worth knowing

    The largest trial was negative

    Meta-analyses of small studies suggested lactoferrin reduced infection in preterm infants; a trial of over two thousand infants then found no effect. Anyone reading enthusiastic summaries of the small-trial literature should know that the definitive study did not confirm it.

  • Worth knowing

    Iron considerations cut both ways

    Interacts withIron supplements, iron overload conditions

    Products differ in iron saturation. Iron-loaded forms add iron, which is unwanted in haemochromatosis or iron overload, while iron-free apolactoferrin binds iron and could in principle reduce availability from a meal. Neither has been well quantified in people.

  • Too much

    Gastrointestinal effects and rash

    Constipation, diarrhoea, rash and loss of appetite have been reported at higher doses. Long-term safety data at supplement doses in adults are limited.

In the food catalogue

The whole-food form, where one exists. The evidence for a concentrated extract rarely transfers to the food, or the other way round — these are cross-links, not equivalents.

Whole milkThe natural source; bovine milk contains lactoferrin at low…

Evidence ratings on this page: 1 limited evidence, 2 not enough evidence.

Supplements are sold in the US without pre-market review of efficacy or safety. Nothing on this page is a recommendation to take Lactoferrin, or a dose to follow.